Dan Li

Dan Li

Central US Merck & Co., Inc. - Kenilworth / United States
Medical and Health Sciences / Pharmacy & Pharmaceutical Sciences
AD Scientific Index ID: 4393597
-
person_outline Dan Li's MOST POPULAR ARTICLES
1-) High-Density Lipoproteins: Nature’s Multifunctional NanoparticlesR Kuai, D Li, YE Chen, JJ Moon, A SchwendemanACS Nano 10, 3015-41, 20162492016
2-) High-density lipoprotein-mimicking nanodiscs for chemo-immunotherapy against glioblastoma multiformeP Kadiyala, D Li, FM Nuñez, D Altshuler, R Doherty, R Kuai, M Yu, ...ACS nano 13 (2), 1365-1384, 20191332019
3-) Predicting drug release kinetics from nanocarriers inside dialysis bagsM Yu, W Yuan, D Li, A Schwendeman, SP SchwendemanJournal of Controlled Release 315, 23-30, 2019672019
4-) Inhibition of 2-hydroxyglutarate elicits metabolic reprogramming and mutant IDH1 glioma immunity in miceP Kadiyala, SV Carney, JC Gauss, MB Garcia-Fabiani, S Haase, ...The Journal of clinical investigation 131 (4), 2021972021
5-) The antitumor activity of a doxorubicin loaded, iRGD-modified sterically-stabilized liposome on B16-F10 melanoma cells: in vitro and in vivo evaluation.K Yu, W Zhang, L Limin, P Song, D Li, R Du, W Ren, W Huang, Dan, Lu, ...Int J Nanomedicine 8, 2473-85, 2013752013